Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.21 Million AUD | 105.01% |
| 2022 | -104.07 Million AUD | -29.27% |
| 2021 | -80.51 Million AUD | -79.36% |
| 2020 | -44.88 Million AUD | -61.08% |
| 2019 | -27.86 Million AUD | -101.5% |
| 2018 | -13.82 Million AUD | -116.87% |
| 2017 | -6.37 Million AUD | -14393.44% |
| 2016 | -44 Thousand AUD | 66.67% |
| 2015 | -132 Thousand AUD | 0.0% |
| 2000 | -497 Thousand AUD | -71.97% |
| 1999 | -289 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 11.68 Million AUD | 0.0% |
| 2023 Q2 | -14.32 Million AUD | 0.0% |
| 2023 FY | 5.21 Million AUD | 105.01% |
| 2023 Q4 | 19.53 Million AUD | 0.0% |
| 2022 Q4 | -33.18 Million AUD | 0.0% |
| 2022 FY | -104.07 Million AUD | -29.27% |
| 2022 Q2 | -70.89 Million AUD | 0.0% |
| 2021 Q4 | -47.99 Million AUD | 0.0% |
| 2021 FY | -80.51 Million AUD | -79.36% |
| 2021 Q2 | -32.51 Million AUD | 0.0% |
| 2020 Q2 | -18.3 Million AUD | 0.0% |
| 2020 FY | -44.88 Million AUD | -61.08% |
| 2020 Q4 | -26.58 Million AUD | 0.0% |
| 2019 FY | -27.86 Million AUD | -101.5% |
| 2019 Q2 | -10.36 Million AUD | 0.0% |
| 2019 Q4 | -17.49 Million AUD | 0.0% |
| 2018 FY | -13.82 Million AUD | -116.87% |
| 2018 Q2 | -5.19 Million AUD | -50.11% |
| 2018 Q1 | -3.45 Million AUD | 28.05% |
| 2018 Q4 | -8.63 Million AUD | 0.0% |
| 2017 Q4 | -4.8 Million AUD | 0.0% |
| 2017 Q2 | -1.57 Million AUD | -0.97% |
| 2017 FY | -6.37 Million AUD | -14393.44% |
| 2017 Q1 | -1.55 Million AUD | 0.0% |
| 2016 Q4 | -1.55 Million AUD | 0.0% |
| 2016 FY | -44 Thousand AUD | 66.67% |
| 2015 FY | -132 Thousand AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | -497 Thousand AUD | -71.97% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 FY | -289 Thousand AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 25.178% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 459.072% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 114.25% |
| Biome Australia Limited | -1.67 Million AUD | 411.998% |
| Patrys Limited | -3.53 Million AUD | 247.239% |
| Orthocell Limited | -7.18 Million AUD | 172.567% |
| Imugene Limited | -149.68 Million AUD | 103.481% |
| Noxopharm Limited | -3.57 Million AUD | 245.635% |
| PYC Therapeutics Limited | -37.72 Million AUD | 113.813% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 141.589% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 163.255% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 181.726% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 153.475% |
| CSL Limited | 2.64 Billion AUD | 99.803% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 159.581% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 316.298% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 85.377% |
| Starpharma Holdings Limited | -8.16 Million AUD | 163.821% |
| Nanollose Limited | -1.15 Million AUD | 550.563% |
| Memphasys Limited | -4.44 Million AUD | 217.311% |
| Invex Therapeutics Ltd | -1.64 Million AUD | 417.394% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | -1507.292% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 215.711% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 137.571% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 281.928% |
| Race Oncology Limited | -13.81 Million AUD | 137.708% |
| Nyrada Inc. | -1.38 Million AUD | 475.912% |
| Dimerix Limited | -17.07 Million AUD | 130.518% |
| PharmAust Limited | -9.03 Million AUD | 157.693% |
| Immutep Limited | -39.89 Million AUD | 113.061% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 112.312% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 127.249% |
| BTC Health Limited | 1.05 Million AUD | -393.799% |
| Acrux Limited | -5.8 Million AUD | 189.845% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 96.683% |
| Biotron Limited | -3.43 Million AUD | 251.636% |
| Tissue Repair Ltd | -4.13 Million AUD | 225.927% |
| AdAlta Limited | -5.38 Million AUD | 196.836% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 110.868% |
| Hexima Limited | -933.87 Thousand AUD | 657.999% |
| AnteoTech Limited | -8.88 Million AUD | 158.679% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 108.884% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 129.504% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 251.634% |
| Actinogen Medical Limited | -13.04 Million AUD | 139.949% |
| Immuron Limited | -6.93 Million AUD | 175.119% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 195.1% |